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Secretory IgA (sIgA),  1 the predominant antibody in milk of most species, is 
not absorbed after ingestion by the nursing infant (1, 2), but acts locally in the 
intestinal  tract  to  protect  against  infections.  To  perform  such  a  role,  the 
antibodies must have immunological specificity for the antigens of intestinal 
microorganisms. Indeed, several observations (3-8)  support the idea that the 
various  specificities  of milk  sIgA reflect prior  antigenic  encounters in  the 
intestinal tract. For example, neutralizing antibodies against the enterotexins 
ofEscherichia coli  and Vibrio cholerae  have been found in human milk (3, 4). 
Furthermore,  the  results  of  colonization  experiments  in  pregnant  women 
suggest  that  lymphoid cells  in  the  gut-associated  lymphoid tissue  (GALT) 
home to the mammary gland where they produce IgA antibodies to intestinal 
microorganisms (5). A  similar suggestion has been made to account for the 
appearance of specific sIgA in milk after oral immunization of rabbits (7). 
In mice, as in humans and rabbits, the predominant Ig in milk is IgA (2, 9, 
10). Its  probable  source is  the  local plasma  cells which lie adjacent to  the 
glandular epithelium of the breast and which dramatically increase in number 
late in pregnancy and during lactation (11). Because IgA plasma cells in the 
intestinal  tract  appear  to be  derived from precursors which emigrate from 
mesenteric  lymph  nodes  (MN)  (12, 13)  and  because  IgA  plasma  cells  in 
mammary  gland  have  been  suggested  to  originate  from  precursors  in  the 
GALT, we decided to test directly whether MN could seed the mammary gland 
with  IgA  plasma  cells.  We  found  that  MN  lymphoblasts  do  home  to  the 
mammary  gland,  but  only  in  the  latter  stages  of pregnancy  and  during 
lactation. Moreover, they give rise to IgA plasma cells at sites where these are 
normally found. Our results thus provide an explanation for the observation 
(3-6) that  IgA antibodies in milk are  specific for antigens  of the  intestinal 
microflora. 
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Materials and Methods 
Mice.  CAF1/J  mice  of both  sexes,  obtained  from  The  Jackson  Laboratory  (Bar  Harbor, 
Maine)  at 7-9 wk of age, were bred in the animal facilities of New York University Medical 
Center. The stage of pregnancy was determined according to methods described in (14). 
Cell Transfers.  The procedure used is fully described in (15). Suspensions of cells from virgin 
young adult females were prepared from MN or peripheral lymph nodes  (PN) in RPMI 1640 me- 
dium with HEPES buffer (Grand Island Biological Co.,  Grand Island, N. Y.) at 0°C. They were 
incubated for 90 min at 37°C in medium containing 10% fetal calf serum (Grand Island Biological 
Co.) and 2 ~Ci/ml of 125I-iodedeoxyuridine (~25IUDR; Amersham/Searle Corp.,  Arlington Heights, 
Ill.)  to  label  cells  synthesizing  DNA.  Occasionally,  the  whole  population  was  labeled  by 
incorporating 20 ~tCi/ml of 5~Cr (as sodium chromate; Amersham/Searle Corp.)  into the labeling 
medium for the last 30 min of incubation. Alternatively, 10 ~Ci/ml of [3H]uridine  (New England 
Nuclear,  Boston,  Mass.)  alone was used.  The cells were then  washed three  times in ice cold 
RPMI 1640 medium and filtered twice through nylon wool to prepare suspensions of single viable 
cells free of unbound label. Approximately 107 cells/recipient were transferred intravenously. In 
some  experiments  selectively-depleted populations  were  transferred.  Populations  depleted  of 
cells bearing surface Ig were prepared by exposing labeled MN cells to rabbit antiserum specific 
for mouse IgA, IgG, or IgM, plus guinea pig complement, for 45  min at 37°C in medium 199 
(Grand Island Biological Co.).  Populations depleted of complement-receptor lymphocytes (CRL) 
were prepared by removing rosette-forming cells on a discontinuous bovine serum albumin gradi- 
ent (16). Suspensions to be injected were washed and filtered as above. In all cases the viability of 
the transferred cells was greater than 90% as assessed by trypan blue dye exclusion. Three or 
four recipients were injected with each cell population. 
Recovery of Label.  Organs  were weighed as  they were removed and  gamma  activity was 
measured in a  Nuclear Chicago gamma counter (Nuclear-Chicago Corp., Des Plaines, Ill.). 3H 
activity was extracted with hot trichloroacetic acid and measured in a Packard Tri-Carb liquid 
scintillation  counter  (Packard  Instrument  Co.,  Inc.,  Downers  Grove,  Ill.)  (15).  Radioactivity 
recovered in recipients is expressed as a percentage of that injected. 
Antisera.  The preparation and specificity of these reagents are fully described in (17). Rabbit 
antisera to mouse IgA, IgG, and IgM were raised against the respective heavy chains isolated 
from partially reduced and alkylated proteins.  These antisera  and  normal rabbit serum were 
absorbed with mouse thymic leukemia cells (L1210) before use. All antisera, with the exception 
of anti-IgA,  were  cytotoxic for  MN  cells in  the  standard  dye  exclusion assay  (17). Anti-IgA 
antiserum was not cytotoxic by this criterion since only a small percentage of the entire MN cell 
population bears IgA, and death of these cells, if it occurred, could not be distinguished from 
background. However, the anti-IgA antiserum was specifically cytotoxic to the population of MN 
blast cells in its effects on homing (see Results). The specificity of the anti-IgA antiserum was 
checked by absorption with the IgA myeloma protein TEPC-15  coupled  to APB-cellulose (18). 
Absorption removed all anti-IgA activity detectable by both Ouchterlony analysis and effects on 
the homing cells. 
lmmunofluoresce~ce  andAutoradiography.  Indirect immunofiuorescence (IF) was used. Com- 
bined immunofluorescence and autoradiography (AR) was performed as previously described (13). 
Results 
Distribution of Radioactivity in Recipients of 125IUDR-Labeled Cells.  The 
percentages of injected radioactivity recovered from recipient mammary glands 
(and small intestines)  16-24 h  after transfer of ~25IUDR-labeled  MN  and PN 
cells  to virgin,  pregnant,  lactating,  and postlactating  mice  are  presented  in 
Table I. Near term and during lactation, recovery of label in mammary glands 
is greater in recipients of MN cells than of PN cells. This preferential seeking 
of the mammary gland by MN lymphoblasts is conveniently expressed by the 
preference  index  (PI),  defined as the ratio of percentage  recovery  of injected 
radioactivity  per gram  of mammary  gland  in  recipients  of MN  cells  versus 
recipients of PN cells.  A  PI above 1 indicates a  greater tendency of MN cells ROUX  ET  AL.  1313 
TABLE  I 
Percent Injected Label Recovered after Transfer of 12~IUDR-Labeled MN and PN Cells 
to Virgin, Pregnant, Lactating, and Postlactating Mice* 
Small intes- 
Recipient mice  Exp.  Donor cells  Mammary gland  PI~ 
tine 
%/g  %/organ  %/organ 
Virgin  1  MN  2.7 ±  2.1  1.6 ±  1.3  1.2  5.7 ±  0.3 
PN  2.2 ±  0.7  0.9 ±  0.2  4.3 ±  0.2 
2  MN  0.4 ±  0.2  0.4 ±  0.2  1.0  4.6 ±  0.8 
PN  0.4 ±  0.1  0.4 ±  0.1  2.6 ±  0.5 
3  MN  0.5 ±  0.2  0.5 ±  0.3  1.2  8.0 ±  1,4 
PN  0.4 ±  0.1  0.6 ±  0.3  1.2 ±  0.2 
9 days antepartum  1  MN  0.3 ±  0.3  0.2 ±  0.1  1.5  4.6 .+  1.2 
PN  0.2 .+  0.1  0.1  ±  0.1  0.6 ±  0.1 
2  MN  1,3 ±  0,8  1.0 ±  0.6  1,4  3.1  ±  0.6 
PN  0.9 ±  1.3  0.9 ±  1.2  1.8 .+  1.1 
1 day antepartum  1  MN  0.8 ±  0.4  1.1  .+ 0.4  4.0  3.1  .+ 0.5 
PN  0.2 .+ 0.1  0.4 ±  0.2  0.8 .+  0.1 
2  MN  3.1  ±  2.0  4,2 ±  2.9  10.3  4.9 .+ 0.5 
PN  0,3 -+  0,0  0.3 ±  0.1  1,1  .+ 0.2 
4 days postpartum  (lactating)  1  MN  2.2 .+ 0.4  3,3 ±  0.9  2,8  3,4 ±  0.4 
PN  0.8 ±  0.4  1,1  .+ 0.5  1,4 ±  0.2 
2  MN  0.6 ±  0.1  1.0 .+  0.2  3.0  5,8 .+  2.2 
PN  0.2 ±  0.1  0,2 ±  0.1  1,4 .+ 0.3 
3  MN  1.6 .+  0.2  4.0 ±  0.4  3.2  4,1  ±  0.6 
PN  0.5 ±  0.1  1.3 .+ 0.4  1.4 .+  0.2 
I0 days postpartum  (lactating)  1  MN  0.8 .+ 0.0  1.5 ±  0.2  1.0  3.9 ±  0.4 
PN  0.8 -+  0.3  1,4 ±  0,5  1.2 .+ 0,4 
2  MN  2.3 ±  1.1  3.5 .+  0.9  3.3  5.1 .+  1.8 
PN  0.7 .+ 0,0  1.3 ±  0.2  1.5 .+ 0.1 
3  MN  1.1 .+  0.3  2.3 .+ 0.6  3.7  5.8 ±  0.7 
PN  0.3 ±  0.2  0.6 .+ 0.4  2.0 .+ 0.2 
20 days postpartum  (lactating)  1  MN  2.1 .+  1.0  3,6 ±  2.2  5.2  3.4 .+  1.0 
PN  0.4 ±  0.2  0.7 ±  0.4  1.4 ±  0.1 
15 days postlactating  1  MN  0.02 ±  0.0  0.03 .+ 0.0  1.0  3.7 ±  0.3 
PN  0.02 .+  0.0  0.03 .+ 0.0  1,3 .+  0.3 
2  MN  0.2 .+ 0.1  0,3 .+ 0.2  0.7  4.2 ±  0.3 
PN  0.3 ±  0.1  0.3 ±  0.1  1.3 .+ 0.2 
* Figures  are the means ±  1 SD of three animals, 
% injected radioactivity/gram mammary gland 
~; PI  - 
in MN recipients 
% injected radioactivity/gram mammary gland in PN recipients 
than PN cells to migrate to the mammary glands, i.e., homing. An index near 
1 indicates  no difference in the behavior of donor cells from the two sources. 
Indices between 0.7 and 1.5 were observed in virgin mice, at 9 days antepartum 
(mid-pregnancy),  and at the postlactating stage. In contrast,  at 1 day antepar- 
tum  and  throughout  the  normal  period of lactation  (20  days),  higher  indices 
were  observed.  The  results  indicate  a  marked  increase  in  the  ability  of 
mammary gland tissue during  late pregnancy and lactation to attract and/or 
retain  MN  lymphoblasts.  This  homing  tendency  by  MN  blasts  is  evident 
whether the index is calculated on a per gram of tissue basis, as in Table I, or 
on a  per organ basis,  a  potentially  important  consideration  since the  glands 
increase in size somewhat variably during pregnancy and lactation. 1314  IgA  PLASMA  CELI~  IN  THE  MAMMARY  GLAND 
TABLE  II 
Combined Recovery of Radioactivity in Mammary Glands and Small Intestine of 
Lactating vs. Nonlactating Mice Injected with the Same Population of MN Blasts 
Exp.  Recipient  mice  Mammary glands  Small intestine 
Mammary 
glands 
plus  small 
intestine 
%~organ  %~organ 
1  4 days postpartum (lactating)  4.0  ±  0.4  4.1  ±  0.6  8.1 
Virgin  0.4  ±  0.2  4.6  ±  0.8  5.0 
2  10 days postpartum (lactating)  9.4  _+  1.7  6.2  ±  1.6  15.6 
Virgin  0.4  _+  0.2  5.7  ±  1.2  6.1 
3  20 days postpartum (lactating)  3.6  ±  2.2  3.4  ±  1.0  7.0 
Postlactating  0.3  ±  0.2  4.2  ±  0.3  4.5 
The percentage of label recovered from the small intestine is also given in 
Table  I.  In  agreement  with  previously  reported  data  (12, 15), MN  blasts 
evidenced  a  greater  tendency  than  PN  blasts  to  go  to  this  site.  Homing 
occurred to the small intestine at all times. 
When 51Cr or [3H]uridine was used to label the entire population of injected 
cells, the distinction between MN and PN cell populations was rarely statisti- 
cally  significant  with  respect  to  either  lactating  mammary gland  or  small 
intestine. 
To determine whether there is competition between mammary gland and gut 
for the same population of cells, we compared the distribution of labeled MN 
blasts  in lactating and nonlactating individuals (Table II).  In each of three 
experiments in which lactating and nonlactating mice were injected with the 
same population of donor cells, the combined recovery of radioactivity in the 
mammary glands  and  small  intestine  was  greater  in  lactating  mice.  The 
possible significance of this finding is discussed later. 
Occurrence of IgA  in Homing Cells  in Recipients.  Sections of mammary 
gland taken from mice injected with labeled lymphoblasts late in pregnancy 
and during lactation were studied by combined AR and IF to determine what 
proportion of the homing lymphoblasts contained IgA.  Table HI  and Fig.  1 
show the results. Although only 5-10% of the labeled MN cells showed IgA in 
the  cytoplasm before  transfer,  the  overwhelming majority  (84-93%~ of the 
labeled cells found in the mammary glands 16-20 h after transfer of MN blasts 
contained IgA. On the other hand, labeled cells of PN origin were less frequent 
in the mammary glands, and although PN blasts could give rise to IgA-positive 
plasmablasts, they did so much less often than MN blasts. 
Effect  of Depletion of Ig-Bearing  Cells or CRL from the Donor Population. 
The previous data show that MN blasts are potentially able to seed the mam- 
mary gland with precursors of IgA plasma cells. Subsequent experiments were 
designed to determine whether the MN blasts which home to the mammary 
gland are precommitted to IgA synthesis, i.e., already produce IgA while still 
in the MN rather than only after emigration. Antisera to IgA, IgG, or IgM, ROUX  ET  AL.  1315 
TABLE  III 
Combined IF and AR of Sections of Mammary Glands of Pregnant and Postpartum 
(Lactating)  Mice Injected  with 125IUDR-Labeled Cells 
Number of* 
Stage of  recipient  Source of  donor  Donor cells  IgA-positive 
cells  Donor cells  donor cells  with IgA 
(AR)  (IF + AR) 
1 day antepartum 
% 
MN  172  150  87 
PN  81  24  30 
MN  42  39  93 
PN  27  8  30 
1 day postpartum  MN  100  90  90 
PN  45  11  24 
MN  63  54  86 
PN  32  13  41 
4 days postpartum  MN  156  143  92 
PN  60  21  35 
MN  91  80  88 
PN  45  20  44 
10 days postpartum  MN  93  84  90 
PN  33  15  45 
MN  101  85  84 
PN  43  21  49 
* Averages per section of the mammary glands of three recipients. 
plus complement, were used to treat labeled cell populations before transfer. 
Results  of such  experiments  are  shown  in  Table  IV.  Anti-IgA  antiserum 
markedly diminished homing to  the  mammary gland  and  small  intestine, 
though  it  consistently gave  a  cytotoxic index  close  to  zero.  This  probably 
reflects  the  fact  that  cells  bearing  IgA  occur  in  limited  numbers  in  the 
population of MN cells taken as a whole, though they represent the bulk of the 
homing  cells.  Anti-IgG  and  anti-IgM  antisera,  on  the  other  hand,  were 
demonstrably cytotoxic but had no effect on homing. Rinsing the cells at 37°C 
(experiment 2) to promote elution of passively adsorbed IgA (13, 19, 20) before 
treatment with anti-IgA antiserum did not alter its effect on homing. Absorp- 
tion of the antiserum with insoluble IgA (experiment 6) did remove its activity. 
The effect of anti-IgA antiserum plus complement on the subsequent homing 
of labeled MN blasts was also assessed by combined IF and AR of recipient 
mammary glands. This treatment reduced both the number of donor cells and 
the percentage containing IgA (Table V). 
Labeled MN  cells were also  depleted of CRL  to  determine whether cells 
homing to the mammary gland lack complement receptors, as do cells homing 
to the gut (15). In two experiments, removal of more than 95% of the CRL had 
no  effect on  homing  to  either  the  mammary gland  or  gut.  Evidently,  B 1316  IgA  PLASMA  CELLS  IN  THE  MAMMARY  GLAND 
Fro.  1.  Combined AR (left) and IF (right) of recipient mammary  gland showing a  donor 
cell producing IgA. 
TABLE  IV 
Effects of Various Antisera, Plus Complement,  on Homing of 125IUDR-Labeled MN 
Cells to Mammary Glands of Lactating  Mice 6 Days Postpartum 
Exp.  Antiserum  Cytotoxic 
index 
Percent injected  label recovered in 
Mammary  glands  Small intestine 
1  NRS*  -  1.3  ±  0.3  5.0  ±  0.4 
anti-IgA  0  0.7  _+  0.0  2.4  ±  0.6 
25  NRS  -  4.3  _  1.1  5.4  ±  0.6 
anti-IgA  0  1.4  _+  0.9  3.0  ±  0.4 
3  NRS  -  7.0  _+  1.6  7.1  __-  0.3 
anti-IgA  1  3.5  _*  0.5  4.5  ±  0.7 
anti-IgM  22  6.0  _+  1.2  6.7  ±  0.4 
4  NRS  -  3.0  _+  1.2  5.7  ±  0.8 
anti-IgA  0  1.7  ±  1.5  2.8  ±  1.3 
anti-IgG  20  2.7  _+  0.5  4.6  _+  1.0 
5  NRS  -  2.2  _+  0.1  4.7  ±  0.3 
anti-IgG  20  3.1  _+  1.6  3.8  ±  0.6 
anti-IgM  38  2.3  _+  0.1  4.6  _+  0.4 
6  NRS  -  7.7  ±  2.9  4.9  ±  0.7 
anti-IgA  0  2.1  ±  0.2  4.0  ±  0.1 
anti-IgA  0  8.0  ±  1.1  5.0  ±  0.1 
absorbed with insoluble IgA 
* Normal rabbit serum. 
5 In experiment 2 the cells  were rinsed three times at 37°C, instead of at 0°C as in the other 
experiments, before treatment. ROUX  ET  AL.  1317 
TABLE V 
Combined IF and AR of Sections of Mammary Glands of Lactating 
Mice Injected  with 12sIUDR-Labeled MN Cells 6 Days Postpartum 
Number of do- 
Treatment of  Number of do-  nor cells with  IgA-positive  do- 
donor cells  nor cells (AR)*  nor cells  IgA (AR +  IF)* 
% 
NRS  27  20  74 
Anti-IgA  12  3  25 
* Averages per section of the mammary glands of three recipients. 
lymphoblasts homing to the mammary gland and small intestine are alike in 
bearing surface IgA and lacking complement receptors. 
Discussion 
Secretory IgA antibodies specific for antigens of gastrointestinal  microorga- 
nisms can be found in milk after oral immunization  (3-7). In the GALT, B cells 
are selectively committed to IgA synthesis (9,  10, 12, 13, 21-30). These observa- 
tions led to the suggestion that intestinal  exposure to microorganisms  stimu- 
lates gut-associated lymphoid cells which migrate to the mammary glands and 
contribute to the antibodies in milk  (5,  7).  Until now, direct proof that GALT 
cells  can  migrate  to  the  mammary  gland  has  been  lacking.  In  the  present 
work,  we  have  shown  that  MN  lymphoblasts  already  committed  to  IgA 
synthesis  can  home  to  the  mouse  mammary  gland  late  in  pregnancy  and 
throughout lactation,  but not to the resting mammary gland. 
We believe that the homing cells are members of the same population which 
regularly homes to the small intestine throughout adult life and gives rise to 
the large numbers of IgA plasma cells found normally in the lamina propria. 
The evidence is as follows: 
(a)  The  ability to  home to both  mammary  gland  and  small  intestine  is  a 
property of MN blast cells, but not resting small lymphocytes. 
(b) Pretreatment with antiserum to IgA, but not to IgG or IgM, in conjunction 
with  complement,  prevents  homing  of MN  lymphoblasts  to  both  mammary 
gland and gut. This treatment is effective after passively adsorbed surface Ig is 
eluted by thorough washing of the donor cells at 37°C. These results imply that 
only IgA-bearing cells home and that their surface IgA is endogenous. 
(c) As in the case of cells homing to the gut  (12,  13),  a  large proportion of 
lymphocytes  homing  to  the  mammary  gland  matures  into  IgA-containing 
plasmablasts within hours of transfer.  In both organs the histological location 
of the homing  donor cells is the same as that of host IgA plasma cells. After 
treatment  with  anti-IgA  antiserum,  relatively  few  of the  transferred  cells 
lodging in either organ contain IgA. 
(d) The B blasts which home to the mammary gland, like those which home 
to the gut (15),  lack receptors for complement. 
(e)  The  spectrum  of antibody specificities produced by IgA plasma  cells in 
mammary gland and intestine is similar  (3-6). 
One piece of evidence seemingly contradicts the hypothesis that one cell type 1318  IgA  PLASMA CELLS IN  THE  MAMMARY GLAND 
homes to both mammary  gland  and  intestine.  On this  hypothesis one  might 
expect,  given a  limited  number of cells capable of homing  to either  location, 
that  they would be distributed  between these  organs  in  lactating  recipients 
and  would  accumulate  in  the  intestine  of nonlactating  recipients.  In  fact, 
however, a larger fraction of cell-associated radioactivity is recovered from the 
mammary  glands  and  small  intestine  of lactating  recipients  than  from  the 
combined  tissues  of nonlactating  recipients  (Table  II).  This  result  could  be 
taken to imply that separate populations of MN blasts are capable of homing to 
the gut versus the mammary gland.  However, we prefer another explanation, 
i.e.,  that  homing  is never entirely efficient,  and  in the  presence of increased 
trapping tissue more total homing can be observed. 
The  actual  mechanism  of homing  to  either  site  is  not  known.  Homing to 
intestine  is  always observed; in  contrast,  homing  to  mammary  gland  occurs 
only  during  late  pregnancy  and  lactation.  This  correlates  with  the  period 
when, under natural conditions, the IgA plasma cell population of the gland is 
increasing most rapidly (11). Thus, homing to the mammary gland,  in contrast 
to the gut, is probably an inducible phenomenon under hormonal  control/ 
The  basic  mechanism  of homing  to  the  gut  must  be  antigen-independent 
since homing of MN blasts to antigen-free grafts of fetal gut has been described 
(12,  31,  32).  The presence of antigen  can, nevertheless,  influence homing.  For 
example,  primed lymphoblasts making IgA specific for cholera toxoid localize 
preferentially  at  sites  of antigen  deposition  in  the  intestine  (33).  Antigen, 
however,  is  unlikely  to  play  a  direct  role  in  homing  of GALT  cells  to  the 
mammary  gland  since  this  organ  appears  not  to  contain  enteric  antigens 
absorbed from the gut (5, 7). 
Recent results  (34,  35) suggest that competition between inflammatory sites 
influences the  migration  of immunoblasts to the gut and,  by analogy,  might 
influence migration to the differentiating mammary gland.  However, T blasts, 
not B blasts, account for the inflammation-induced  increase of cells in the gut 
(34).  The  finding  (35)  that  labeled thoracic  duct lymphoblasts from parasite- 
infested rats accumulated in increased amounts in mammary glands of lactating 
syngeneic rats  probably parallels  our own.  However, the  association of label 
with particular populations of T or B lymphoblasts was not studied. 
Our  demonstration  that  B  lymphoblasts  committed  to  IgA synthesis  have 
the potential to leave GALT and home to the mammary gland does not exclude 
the possibility that T  cells derived from GALT can follow a  similar  pathway. 
This  idea  is  supported  by the  finding  that  T  lymphocytes  in  milk  respond 
selectively to enteric  antigens  (36,  37).  The possibility should be entertained 
that  GALT-derived  T  cells  play  a  role  in  development  of the  secretory  IgA 
system in the mammary gland. 
It  now seems reasonable  to  incorporate  the  mammary  gland  into  a  model 
previously  proposed  by  ourselves  and  others  (9,  12,  27-30,  33,  38)  for  the 
circulation  of IgA  immunocytes  to  the  gut.  This  model  is  shown  in  Fig.  2. 
Precursors of IgA plasma cells originally encounter antigen  in Peyer's patches 
2 Weisz-Carrington, P.,  M.  E.  Roux, M.  McWilliams, J.  M.  Phillips-Quagliata, and M. E. 
Lamm. Hormonal induction of the secretory immune system in the mammary gland. Manuscript 
submitted for publication. ROUX  ET  AL.  1319 
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Model for the circulation of IgA immunocytes  to the gut and mammary gland. 
Lymphocytes  originating in PP migrate to MN, where they divide and differentiate. They 
leave the MN via the thoracic duct and peripheral blood to lodge  in the lamina propria of 
the gut or, during late pregnancy and lactation, the intralobular connective  tissue of the 
mammary gland, where they assume the appearance of plasma cells. 
(PP).  They  migrate  to  the  MN,  where  they  divide  and  differentiate.  The 
precursors are clearly committed to IgA synthesis before leaving the MN, and 
probably before  leaving the  PP.  Via  the thoracic duct and  peripheral  blood 
they reach the lamina propria of the small intestine. During late pregnancy 
and lactation, these cells also lodge in the periglandular connective tissue of 
the mammary gland, which is postulated to contain the same receptor as the 
intestine.  In  these  latter sites,  maturation into fully developed IgA plasma 
cells  occurs.  Moreover,  it  is  likely  that  GALT  is  capable  under  natural 
conditions of supplying B cells to other parts of the secretory immune system 
as well. Indeed, under experimental conditions, PP can repopulate the respira- 
tory tract with IgA plasma cells, and cells from bronchial lymphoid tissue can 
serve in the same capacity to the gut  (27). Under appropriate circumstances 
exposure  to  antigen at one  secretory surface containing organized lymphoid 
tissue might thus confer adaptive immunity at other secretory surfaces. This 
has obvious implications for prophylaxis against disease. 
Summary 
Lymphoblasts from the mesenteric lymph nodes (MN)  of mice home to the 
mammary glands of syngeneic recipients late in pregnancy and during lacta- 
tion, and within hours of transfer most can be shown to contain IgA. Homing 
does not occur in virgins, in early pregnancy, or after weaning. Homing MN 
lymphoblasts are sensitive to antiserum to IgA plus complement, but not to 
other class-specific antisera. Thus, lymphoblasts in MN with the potential to 1320  IgA  PLASMA  CELLS  IN  THE  MAMMARY  GLAND 
home to the mammary gland are already committed to IgA synthesis and bear 
surface IgA before reaching their destination.  These results  explain observa- 
tions,  made by others, of specific IgA antibodies and IgA plasma cells in milk 
and  colostrum after oral immunization.  Under  natural  conditions it is likely 
that  IgA  precursor  cells,  after  stimulation  in  the  gut-associated  lymphoid 
tissue  by  intestinal  antigens,  migrate  to  the  mammary  gland  where  they 
secrete  antibodies  which  constitute  an  important  defense  mechanism  of the 
newborn.  In  the  absence  of lactation,  these  cells  probably  form  part  of the 
normal traffic to the lamina propria of the small intestine. 
Received for publication 3 August 1977. 
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